OTCMKTS:NXNN

Nexeon Medsystems (NXNN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
300 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NXNN stock logo

About Nexeon Medsystems Stock (OTCMKTS:NXNN)

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

NXNN Stock News Headlines

Nexeon MedSystems Inc NXNN
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Nexeon MedSystems Inc. (NXNN)
See More Headlines
Receive NXNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexeon Medsystems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/21/2018
Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:NXNN
CIK
N/A
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
6.98
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. William Rosellini J.D. (Age 44)
    M.B.A., M.S., Chairman & CEO
    Comp: $2
  • Mr. Christopher R. Miller (Age 54)
    Chief Financial Officer
    Comp: $131.75k
  • Mr. Cathal Mc Fadden
    Vice President of Operations
  • Dr. Austin Duke Ph.D.
    Chief Science Officer

NXNN Stock Analysis - Frequently Asked Questions

How were Nexeon Medsystems' earnings last quarter?

Nexeon Medsystems Inc (OTCMKTS:NXNN) issued its quarterly earnings data on Monday, May, 21st. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.03. The firm earned $2.87 million during the quarter, compared to the consensus estimate of $1.70 million.

What other stocks do shareholders of Nexeon Medsystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nexeon Medsystems investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Fate Therapeutics (FATE), ObsEva (OBSV), Vaxart (VXRT), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AC Immune (ACIU), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

How do I buy shares of Nexeon Medsystems?

Shares of NXNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:NXNN) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners